Articles

Tirzepatide, GIP(1-42) and GIP(1-30) display unique signaling profiles at two common GIP receptor variants, E354 and Q354

in Experimental Pharmacology and Drug Discovery

• Tayla A. Rees
• Benjamin J. Buttle
• Zoe Tasma
• Sung-Hyun Yang
• Paul W. R. Harris
• Christopher S. Walker

The evolution of the therapeutic concept ‘GIP receptor antagonism’

in Diabetes: Molecular Mechanisms

• Frederikke Koefoed-Hansen
• Mads Marstrand Helsted
• Hüsün Sheyma Kizilkaya
• Asger Bach Lund
• Mette Marie Rosenkilde
• Lærke Smidt Gasbjerg

The Insulin Response to Oral Glucose in GIP and GLP-1 Receptor Knockout Mice: Review of the Literature and Stepwise Glucose Dose Response Studies in Female Mice

in Gut Endocrinology

• Bo Ahrén
• Yuichiro Yamada
• Yutaka Seino

The Effect of Cell Surface Expression and Linker Sequence on the Recruitment of Arrestin to the GIP Receptor

in Experimental Pharmacology and Drug Discovery

• Suleiman Al-Sabah
• Lobna Adi
• Moritz Bünemann
• Cornelius Krasel

The role of GIPR in food intake control

in Diabetes: Molecular Mechanisms

• Paula-Peace James-Okoro
• Jo Edward Lewis
• Fiona Mary Gribble
• Frank Reimann

Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes

in Clinical Diabetes

• Qiming Tan
• Seun E. Akindehin
• Camila E. Orsso
• Richelle C. Waldner
• Richard D. DiMarchi
• Timo D. Müller
• Andrea M. Haqq

Glucagon-like peptide 1 and glucose-dependent insulinotropic peptide hormones and novel receptor agonists protect synapses in Alzheimer’s and Parkinson’s diseases

• Christian Hölscher

Impact of Incretin Hormone Receptors on Insulin-Independent Glucose Disposal in Model Experiments in Mice

in Cellular Endocrinology

• Tina Ovlund
• Giovanni Pacini
• Bo Ahrén

Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats

in Translational and Clinical Endocrinology

• Sara Baldassano
• Lærke Smidt Gasbjerg
• Hüsün Sheyma Kizilkaya
• Mette Marie Rosenkilde
• Jens Juul Holst
• Bolette Hartmann

GIPR Signaling in Immune Cells Maintains Metabolically Beneficial Type 2 Immune Responses in the White Fat From Obese Mice

in Inflammation

• Irina Efimova
• Inbar Steinberg
• Isabel Zvibel
• Anat Neumann
• Dana Fernanda Mantelmacher
• Daniel J. Drucker
• Sigal Fishman
• Chen Varol

Activation of GIPR Exerts Analgesic and Anxiolytic-Like Effects in the Anterior Cingulate Cortex of Mice

in Neuroendocrine Science

• Xin-shang Wang
• Yong-li Jiang
• Liang Lu
• Ban Feng
• Xue Ma
• Kun Zhang
• Shao-yu Guan
• Le Yang
• Qing-yu Fan
• Xiao-chen Zhu

Coexistence of Myelolipoma and Primary Bilateral Macronodular Adrenal Hyperplasia With GIP-Dependent Cushing's Syndrome

in Neuroendocrine Science

• Stéphanie Larose
• Louis Bondaz
• Livia M. Mermejo
• Mathieu Latour
• Odile Prosmanne
• Isabelle Bourdeau
• André Lacroix